This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Aggressive Prostate Cancers in Elderly Patients

This study has been completed.
Information provided by:
Seoul National University Hospital Identifier:
First received: April 29, 2011
Last updated: May 18, 2011
Last verified: May 2011
Patients aged 70 years or older had a higher possibility of high risk cancer than younger patients.

Prostatic Neoplasms

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Retrospective
Official Title: Patients Aged More Than 70 Had More Aggressive Prostate Cancers and Higher Risk of Biochemical Recurrence in Korea

Resource links provided by NLM:

Further study details as provided by Seoul National University Hospital:

Primary Outcome Measures:
  • biochemical recurrences (BCR) [ Time Frame: 5 year-BCR ]
    BCR was defined as two consecutive increasing PSA values of more than 0.2 ng/mL

Secondary Outcome Measures:
  • pathologic outcomes [ Time Frame: postoperative 1 week ]
    biopsy or pathologic Gleason scores, mean percent of positive cores and tumor volume percent, Extracapsular extension and seminal vesicle invasion

Enrollment: 1333
Study Start Date: January 2010
Study Completion Date: October 2010
Primary Completion Date: October 2010 (Final data collection date for primary outcome measure)
patients older than 70 years
patients 70 years or younger

Detailed Description:
Patients aged 70 years or older had a higher risk of advanced prostate cancer and shorter BCR-free survival than younger ones. Definite treatment of clinically localized prostate cancer should be actively considered in well-selected healthy patients older than 70 years.

Ages Eligible for Study:   40 Years to 80 Years   (Adult, Senior)
Sexes Eligible for Study:   Male
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Men who underwent radical prostatectomy for the treatment of clinically localized prostate cancer

Inclusion Criteria:

  • clinically localized prostate cancer
  • good health status
  • follow-up period more than 12 months

Exclusion Criteria:

  • insufficient clinical data
  • poor health status
  • clinically advanced prostate cancer
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT01347476

Korea, Republic of
Seoul National University Boramae Hospital
Seoul, Korea, Republic of
Sponsors and Collaborators
Seoul National University Hospital
Principal Investigator: Sung Yong Cho, M.D. Seoul National University Hospital
  More Information

Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: Seoul National University Boramae Hospital Identifier: NCT01347476     History of Changes
Other Study ID Numbers: old age prostate
elderly pts with high risk CaP
Study First Received: April 29, 2011
Last Updated: May 18, 2011

Keywords provided by Seoul National University Hospital:
prostate-specific antigen
radical prostatectomy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Genital Diseases, Male
Prostatic Diseases processed this record on June 23, 2017